open access

Vol 50, No 3 (2012)
ORIGINAL PAPERS
Submitted: 2012-10-08
Accepted: 2012-10-08
Get Citation

Use of X-ray microprobe to diagnose bone tissue demineralization after caffeine administration

Marek Tomaszewski, Grazyna Olchowik, Monika Tomaszewska, Franciszek Burdan
DOI: 10.5603/FHC.2012.0060
·
Folia Histochem Cytobiol 2012;50(3):436-443.

open access

Vol 50, No 3 (2012)
ORIGINAL PAPERS
Submitted: 2012-10-08
Accepted: 2012-10-08

Abstract

Caffeine is a methylxanthine which permeates the placenta. In studies on animals, it has been
shown to produce teratogenic and embryotoxic effects in large doses. The objective of this study was to
assess the influence of caffeine on the development of bone tissue, with particular reference to elemental
bone composition using an X-ray microprobe. The research was conducted on rats. The fertilized females
were randomly divided into an experimental and a control group. The experimental group was
given caffeine orally in 30 mg/day doses from the 8th to the 21st day of pregnancy, while the control group
was given water. The fetuses were used to assess the growth and mineralization of the skeleton. On the
basis of double dyeing, a qualitative analysis of the bone morphology and mineralization was conducted.
For calcium and potassium analysis, an X-ray microprobe was used. In 67 fetuses from the experimental
group, changes in skeleton staining with the alcian-alizarin method were noticed. The frequency of the
development of variants in the experimental group was statistically higher. In the experimental group,
a significant decrease in the calcium level, as well as an increase in the potassium level, was observed.
The X-ray microprobe’s undoubted advantage is that is offers a quick qualitative and quantitative analysis
of the elemental composition of the examined samples. Employing this new technique may furnish us
with new capabilities when investigating the essence of the pathology process.

Abstract

Caffeine is a methylxanthine which permeates the placenta. In studies on animals, it has been
shown to produce teratogenic and embryotoxic effects in large doses. The objective of this study was to
assess the influence of caffeine on the development of bone tissue, with particular reference to elemental
bone composition using an X-ray microprobe. The research was conducted on rats. The fertilized females
were randomly divided into an experimental and a control group. The experimental group was
given caffeine orally in 30 mg/day doses from the 8th to the 21st day of pregnancy, while the control group
was given water. The fetuses were used to assess the growth and mineralization of the skeleton. On the
basis of double dyeing, a qualitative analysis of the bone morphology and mineralization was conducted.
For calcium and potassium analysis, an X-ray microprobe was used. In 67 fetuses from the experimental
group, changes in skeleton staining with the alcian-alizarin method were noticed. The frequency of the
development of variants in the experimental group was statistically higher. In the experimental group,
a significant decrease in the calcium level, as well as an increase in the potassium level, was observed.
The X-ray microprobe’s undoubted advantage is that is offers a quick qualitative and quantitative analysis
of the elemental composition of the examined samples. Employing this new technique may furnish us
with new capabilities when investigating the essence of the pathology process.
Get Citation
About this article
Title

Use of X-ray microprobe to diagnose bone tissue demineralization after caffeine administration

Journal

Folia Histochemica et Cytobiologica

Issue

Vol 50, No 3 (2012)

Pages

436-443

DOI

10.5603/FHC.2012.0060

Bibliographic record

Folia Histochem Cytobiol 2012;50(3):436-443.

Authors

Marek Tomaszewski
Grazyna Olchowik
Monika Tomaszewska
Franciszek Burdan

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl